‘Cancer drugs in Europe only months later on the market than in the US’ | NOW
New cancer drugs are on the market only eight months later in Europe than in the United States, it reports AD Tuesday in response to a study by Professor Carin Uyl-de Groot of Erasmus University Rotterdam. The delay would lead to an earlier and unnecessary death of people here. A new cancer drug comes onto … Read more